Samuel R Lehman

M.D. | Neurology


  10550 Quivira Rd, Suite 530, Overland Park
     Kansas, 66215-2306
  913-599-3828    913-599-3451 Maps & Directions
Samuel R Lehman is a Overland Park, Kansas based neurologist who is specialized in Neurology. His current practice location is 10550 Quivira Rd, Suite 530, Overland Park. Patients can reach him at 913-599-3828 or can fax him at 913-599-3451. Samuel R Lehman is M.D. in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1811939929.
Samuel R Lehman specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Samuel R Lehman speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Samuel R Lehman
Specialization: Neurology
Gender:Male
Credentials: M.D.
Practice Address:10550 Quivira Rd, Suite 530, Overland Park,
Kansas, 66215-2306
Phone:913-599-3828
Fax:913-599-3451
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1811939929
NPI Enumeration Date: 12 Jun, 2006
NPI Last Update On: 07 Feb, 2019

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Samuel R Lehman
1000 Carondelet Dr, Provider Enrollment/med Staff Ofc
Kansas City, Missouri
Zip: 64114
Phone Number: 816-943-5744
Patients can reach Samuel R Lehman at 10550 Quivira Rd, Suite 530, Overland Park, Kansas or can call to book an appointment on 913-599-3828.
Comments/ Reviews:

Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.